How many institutions held FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in Q2 2019?

25 institutional investors reported FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value for Q2 2019. Use the holders table for investor-level position and value details.

FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Q: What does CUSIP 31447P100 represent in this 13F holders report?

CUSIP 31447P100 is the security identifier for FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 31447P100

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 34,763,175
Total 13F shares: 8,988,085
Share change: -617,661
Total reported value: $35,952,664
Price per share: $4.00
Number of holders: 25
Value change: -$3,100,726
Number of buys: 8
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 31447P100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Southpoint Capital Advisors LP	13F	Company	11%	3,997,214	$19,386,000	—	31 Mar 2019	13F
Avoro Capital Advisors LLC	13F	Company	3.2%	1,105,999	$5,364,000	—	31 Mar 2019	13F
683 Capital Management, LLC	13F	Company	2.8%	971,351	$4,711,000	—	31 Mar 2019	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	2.1%	720,000	$3,492,000	—	31 Mar 2019	13F
Opaleye Management Inc.	13F	Company	1.8%	630,000	$3,056,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	1.6%	539,779	$2,618,000	—	31 Mar 2019	13F
Granahan Investment Management, LLC	13F	Company	1.2%	410,932	$1,993,000	—	31 Mar 2019	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.75%	262,033	$1,271,000	—	31 Mar 2019	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.5%	174,050	$844,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.48%	167,372	$812,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.29%	102,077	$495,000	—	31 Mar 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.24%	84,750	$411,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	46,059	$223,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	46,134	$222,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	0.13%	45,067	$219,000	—	31 Mar 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.12%	42,165	$205,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.09%	31,100	$151,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.08%	27,211	$132,000	—	31 Mar 2019	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.07%	25,000	$121,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.07%	22,789	$111,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	18,673	$91,000	—	31 Mar 2019	13F
Zebra Capital Management LLC	13F	Company	0.05%	17,568	$85,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	15,600	$76,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	15,408	$75,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.04%	15,254	$74,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	13,375	$65,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	12,626	$61,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	12,400	$60,000	—	31 Mar 2019	13F
Hartford Financial Management Inc.	13F	Company	0.04%	12,300	$60,000	—	31 Mar 2019	13F
Wealthspire Advisors, L.P.	13F	Company	0.03%	9,500	$46,000	—	31 Mar 2019	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0.03%	9,304	$44,000	—	31 Mar 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	7,710	$37,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.01%	3,535	$17,000	—	31 Mar 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	3,512	$17,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.01%	3,416	$17,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.01%	3,313	$16,000	—	31 Mar 2019	13F
STRS OHIO	13F	Company	0.01%	3,300	$16,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	2,831	$14,000	—	31 Mar 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.01%	2,660	$12,901	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	2,323	$11,000	—	31 Mar 2019	13F
Legal & General Group Plc	13F	Company	0%	1,681	$8,000	—	31 Mar 2019	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	914	$4,000	—	31 Mar 2019	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	315	$2,000	—	31 Mar 2019	13F
UBS Group AG	13F	Company	0%	311	$2,000	—	31 Mar 2019	13F
ROYAL BANK OF CANADA	13F	Company	0%	203	$1,000	—	31 Mar 2019	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	1	$5	—	31 Mar 2019	13F

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q2 2019

As of 30 Jun 2019, FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,988,085 shares. The largest 10 holders included Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, 683 Capital Management, LLC, Solas Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Opaleye Management Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, NORTHERN TRUST CORP, and OxFORD Asset Management LLP. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

-19

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.